AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lipocine Inc. Director's Dealing 2013

Dec 12, 2013

Director's Dealing

Opens in your device viewer

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2013-12-10

Reporting Person: BROWN MORGAN R (EVP and CFO)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-10	Stock Option (Right to Buy)	$8.1	A	15000	Acquired	2023-12-10	Common Stock (15000)	Direct
2013-12-10	Restricted Stock Unit	$1	A	5000	Acquired	2023-12-10	Common Stock (5000)	Direct